Tigermed Reports RMB 272 Million Net Loss Attributable to Shareholders for First Three Quarters, Reversing Year-Earlier Profit

Stock News10-29

Hangzhou Tigermed Consulting Co., Ltd. (03347) has released its results for the first three quarters of 2026.

According to the announcement, the company recorded operating revenue of RMB 5.792 billion for the first three quarters, representing a year-on-year increase of 15.23%.

Net loss attributable to shareholders of the parent company stood at RMB 272 million, swinging to a loss from a profit in the same period last year.

Basic loss per share came in at RMB 0.32.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment